Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.41 |
| ▸ | CTRC | Q99895 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19254235 | 0.92 | CTRC (0.44) | TYRMAPTTSHRTP53HTT | |
| SCHEMBL13763448 | 0.85 | TP53 (0.43) | TYRMAPTTSHRTP53HTT | |
| SCHEMBL9486060 | 0.85 | TYR (0.50) | TYRMAPTTSHRTP53HTT | |
| SCHEMBL9921245 | 0.84 | MAPT (0.38) | MAPTTSHRCYP3A4KMT2ARAB9A | |
| SCHEMBL11775528 | 0.83 | ACLY (0.49) | TYRMAPTTSHRTP53HTT | |
| SCHEMBL16224885 | 0.83 | ACLY (0.49) | TYRMAPTTSHRTP53HTT | |
| SCHEMBL2355598 | 0.82 | TAAR1 (0.40) | MAPTTSHRTP53MEN1CYP3A4 | |
| SCHEMBL24543287 | 0.81 | GABRA1 (0.37) | MAPTRAB9AATML3MBTL1NPC1 | |
| SCHEMBL29673152 | 0.81 | GABRA1 (0.37) | MAPTRAB9AATML3MBTL1NPC1 | |
| SCHEMBL10412816 | 0.81 | TYR (0.50) | TYRMAPTTSHRTP53HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2797880-B1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILEPSY | BIO-PHARM SOLUTIONS CO LTD (KR) | 2017-03-01 | — | — | EP | disclosed |
| US-20160075651-A1 | GLYCOLIPID INHIBITION USING IMINOSUGARS | UNITHER VIROLOGY, LLC (US) | 2016-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160075651-A1 | GLYCOLIPID INHIBITION USING IMINOSUGARS | UGCG, UGGT1, DGAT1 | TYR 2892/4885MAPT 1473/4885TSHR 3108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.